Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01957722 · ClinicalTrials.gov registry record · Phase 3
NOVOCART®3D for Treatment of Articular Cartilage of the Knee
A Phase 3 study of Articular Cartilage of the Femoral Condyle Between 2-6cm2, sponsored by Aesculap Biologics.
- Active
- Registry status
- Phase 3
- Development phase
- 233
- Enrollment target
- 20
- Study locations
NCT01957722: Active Phase 3 study of Articular Cartilage of the Femoral Condyle Between 2-6cm2, sponsored by Aesculap Biologics.
NCT01957722 is a Phase 3 study of Articular Cartilage of the Femoral Condyle Between 2-6cm2 that is active but no longer recruiting, run by Aesculap Biologics. The registered enrollment target is 233 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower). The trial reports 20 study locations across 12 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01957722, a Phase 3 study of Articular Cartilage of the Femoral Condyle Between 2-6cm2, is active but no longer recruiting, sponsored by Aesculap Biologics.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 3
- Development phase
- 233 participants
- Enrollment target
- 20
- Study locations
Study Summary
This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.
Primary Outcome
As measured by a change in KOOS (pain subdomain) score at 24 months from baseline
Conditions Studied
Interventions
- PROCEDURE Microfracture
- BIOLOGICAL NOVOCART 3D
Study Locations (20)
California
- Grossmont Orthopaedic Medical Group - La Mesa
- UCLA - Los Angeles
- Stanford Medicine - Redwood City
New York
- Mount Sinai Faculty Practice Associates - New York
- Plancher Orthopaedics & Sports Medicine - New York
- Long Island Bone and Joint Llp - Port Jefferson
Colorado
- Cu Sports Medicine - Denver
- Yampa Valley Medical Center - Steamboat Springs
Florida
- Tenet Florida Physician Services - Boca Raton
- Paley Orthopedic and Spine Institute - West Palm Beach
Illinois
- Rush University Medical Center - Chicago
- Northshore University Health System - Evanston
Minnesota
- Tria Orthopaedic Center - Bloomington
- Mayo Clinic - Rochester
Idaho
- Saint Alphonsus Medical Group - Meridian
Kentucky
- University of Kentucky - Lexington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 233 participants |
| Start Date | 2013-12 |
| Est. Completion | 2027-12 |
| Phase | Phase 3 |
What the registry record for NCT01957722 still lists
NCT01957722 is an interventional study that assigns participants to a tested intervention. The registered 233 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (70% lower).
The record links to 1 condition, with Articular Cartilage of the Femoral Condyle Between 2-6cm2 appearing as the primary indexed condition, and to 2 interventions - of which Microfracture is the first listed.
NCT01957722 names 20 study sites across 12 states, led by California, New York, Colorado.
Frequently Asked Questions
What is clinical trial NCT01957722 about?
NCT01957722 is a clinical study titled "NOVOCART®3D for Treatment of Articular Cartilage of the Knee". This study is to compare NOVOCART 3D relative to Microfracture for the treatment of knee cartilage defects. Efficacy will be evaluated by both pain and function. Safety will also be evaluated.
What is the current status of trial NCT01957722?
This trial is currently active not recruiting. It is a Phase 3 study. The enrollment target is 233 participants. The study started on 2013-12. Estimated completion is 2027-12.
What conditions does trial NCT01957722 study?
This clinical trial studies the following conditions: Articular Cartilage of the Femoral Condyle Between 2-6cm2.
What interventions are being tested in trial NCT01957722?
The interventions under investigation include: Microfracture (PROCEDURE), NOVOCART 3D (BIOLOGICAL).
Who is sponsoring clinical trial NCT01957722?
This trial is sponsored by Aesculap Biologics, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01957722 being conducted?
This trial has 20 study locations across California, Colorado, Florida, Idaho, Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01957722's enrollment target sits among peer trials
233 1298th of 2000 higher than 703 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06993844 · 233 participants · Phase 1
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
- NCT07141706 · 233 participants · Phase 1
A Study of DB-1317 in Selected Advanced/Metastatic Solid Tumors
- NCT04942717 · 234 participants · NA
Adapting for Latinx Populations an Intervention That Involves Discussing and Sharing Patients' Health-Related Values
- NCT05208671 · 234 participants · NA
Nutrition to Optimize, Understand, and Restore Insulin Sensitivity in HIV for Oklahoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia